In contrast, CLU exhibited elevated expression levels in kidney renal clear cell carcinoma (KIRC), kidney renal papillary cell carcinoma (KIRP), thyroid carcinoma (THCA), and GBM when compared to tissues from matched control samples (Figure 1A). The gene discussed is CLU; the disease is glioblastoma.